Erector Spinae Block Versus Caudal Block for Perioperative Analgesia in Pediatric Cancer Patients
Sponsor
National Cancer Institute, Egypt (Other)
Overall Status
Recruiting
CT.gov ID
NCT05153720
Collaborator
(none)
78
1
2
11.4
6.9
Study Details
Study Description
Brief Summary
The study aim to compare ultrasound guided erector spinae plane block versus ultrasound guided caudal block in perioperative analgesia for pediatric cancer patients
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
78 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Comparison of Ultrasound Guided Erector Spinae Block and Ultrasound Guided Caudal for Perioperative Analgesia in Pediatric Cancer Patients Undergoing Nephrectomy Surgeries: A Randomized Controlled Study
Actual Study Start Date
:
Dec 20, 2021
Anticipated Primary Completion Date
:
Nov 1, 2022
Anticipated Study Completion Date
:
Dec 1, 2022
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Ultrasound guided erector spinae plane block Unilateral erector spinae plane block will be performed under ultrasound guidance |
Procedure: Erector spinae plane block
Ultrasound guided erector spinae plane block
|
Active Comparator: Ultrasound guided caudal block Caudal block will be formed under ultrasound guidance |
Procedure: Caudal block
Ultrasound guided caudal block
|
Outcome Measures
Primary Outcome Measures
- opioid consumption [First 24 hours postoperatively]
postoperative morphine consumption
Eligibility Criteria
Criteria
Ages Eligible for Study:
1 Year
to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
ASA I and II
-
Age >1 and <12
-
patients undergoing nephrectomy surgeries
Exclusion Criteria:
-
patients parental refusal
-
local infection at the puncture site
-
coagulopathy with INR> 1.6
-
unstable cardiovascular disease
-
patients allergic to medication used
-
development or mental delay
-
impaired liver and renal functions
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Walaa Y Elsabeeny | Cairo | Egypt | 11796 |
Sponsors and Collaborators
- National Cancer Institute, Egypt
Investigators
- Principal Investigator: Walaa Y Elsabeeny, MD, Lecturer of Anesthesia and Pain Management, National Cancer Institute, Cairo University
- Principal Investigator: Yasmen F Abdelghani, M.Sc, Assistant Lecturer of Anesthesia and Pain Management, National Cancer Institute, Cairo University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Walaa Youssef Elsabeeny,
Lecturer of Anesthesia and Pain management,
National Cancer Institute, Egypt
ClinicalTrials.gov Identifier:
NCT05153720
Other Study ID Numbers:
- AP2109-30109
First Posted:
Dec 10, 2021
Last Update Posted:
Jan 10, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: